Dr. Falk Pharma engaged RSD to support an Australian awareness campaign for a newly identified condition. The campaign required scale, efficiency, and strict alignment with platform and industry guidelines.
RSD worked alongside creative partner Hoozu, who sourced and produced 11 creator-led assets across five creators.
RSD led paid media strategy and execution across Australia, including:
Every test, optimisation and budget shift was guided by performance data — doubling down only where results justified it.
Dr. Falk Pharma ran this campaign internationally with local agencies. RSD was selected to lead Paid Media for Australia, with results that outperformed other regions globally.
RSD has since been re-engaged through to 2026, leading paid media strategy and informing creative direction for the next evolution of the campaign.
